You are here

  • Home
  • Archive
  • Volume 6, Issue 4
  • Review: ACE inhibitors, calcium antagonists, and more intensive blood pressure lowering strategies reduce cardiovascular events

Article Text

Article menu
Download PDFPDF
Therapeutics
Review: ACE inhibitors, calcium antagonists, and more intensive blood pressure lowering strategies reduce cardiovascular events

https://doi.org/10.1136/ebm.6.4.111

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Footnotes

    • Sources of funding: National Health and Medical Research Council of Australia; Medical Foundation of the University of Sydney; National Heart Foundation of Australia; Health Research Council of New Zealand; British Heart Foundation; International Society of Hypertension; AstraZeneca; Bayer A G; Bristol Myers-Squibb; Glaxo Wellcome SpA; Hoechst A G; Merck; Pfizer; Searle and Servier.

    • For correspondence: Dr B Neal, Blood Pressure Lowering Treatment Trialists' Collaboration, Institute for International Health, University of Sydney, PO Box 576, Newtown, Sydney, New South Wales 2042, Australia. Fax +61 2 9351 0064.